PubMed Health⌕ Search

PubMed · 6741961

Bid solicitation and contract negotiation.

Abstract

The process of soliciting bid prices for drug products and of negotiating contracts with pharmaceutical vendors is reviewed. The primary purpose of bid purchasing is to obtain drugs at the lowest price and to have these prices remain fixed for a predetermined period of time. A successful bid-purchasing process depends on the institution's implementation of a formulary brand-standardization policy, prior identification of acceptable vendors and drug products, and establishment of criteria for evaluating drugs under a bid-purchasing system. Specific information to be included in the invitation to bid and useful data other than drug prices that may be solicited from vendors are outlined. Manual and computerized systems for organizing bid-request data are described. Bid evaluations should maintain the confidentiality of bid and contract prices. Selection of winning bids is based on lowest price or, in cases where prices are identical, on selected vendor characteristics or services. Negotiation of unacceptable bid prices should be conducted with a thorough knowledge of the needs and goals of the institution and the vendor. Procedures for establishing contracts and the timing of various phases of the bid process are discussed. An optimal bid-purchasing system is achieved only when the system is carefully planned and designed and when each prospective vendor is given an equal opportunity to establish a contractual relationship with the institution.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J C McAllister. 1984. Bid solicitation and contract negotiation.. https://pubmed.ncbi.nlm.nih.gov/6741961/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

ACOG Committee Opinion No. 359: commercial enterprises in medical practice.

Increasing numbers of physicians sell and promote both medical and nonmedical products as part of their practices. Physicians always have rendered advice and treatment for a fee, and this practice is appropriate. It is unethical under most circumstances, however, for physicians to sell or promote medical or nonmedical products or services for their financial benefit. The following activities are considered unethical: sale of prescription drugs to be used at home, sale or promotion of nonprescription medicine, sale or promotion of presumptively therapeutic agents that generally are not accepted as part of standard medical practice, sale or promotion of non-health-related items, recruitment of patients or other health care professionals into multilevel marketing arrangements, and sale or promotion of any product in whose sale the physician has a significant financial interest. It is ethical and appropriate, however, to sell products to patients as follows: sale of devices or drugs that require professional administration in the office setting; sale of therapeutic agents, when no other facilities can provide them at reasonable convenience and at reasonable cost; sale of products that clearly are external to the patient-physician relationship, when such a sale would be considered appropriate in an external relationship; and sale of low-cost products for the benefit of community organizations. A rationale is provided for both the prohibited activities and exceptions.

Commerce↗